ZA200505214B - Preparation of quinapril hydrochloride - Google Patents

Preparation of quinapril hydrochloride

Info

Publication number
ZA200505214B
ZA200505214B ZA200505214A ZA200505214A ZA200505214B ZA 200505214 B ZA200505214 B ZA 200505214B ZA 200505214 A ZA200505214 A ZA 200505214A ZA 200505214 A ZA200505214 A ZA 200505214A ZA 200505214 B ZA200505214 B ZA 200505214B
Authority
ZA
South Africa
Prior art keywords
preparation
quinapril hydrochloride
quinapril
hydrochloride
Prior art date
Application number
ZA200505214A
Other languages
English (en)
Inventor
Jennings Sandra Marie
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200505214B publication Critical patent/ZA200505214B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200505214A 2003-03-31 2005-06-28 Preparation of quinapril hydrochloride ZA200505214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45901603P 2003-03-31 2003-03-31

Publications (1)

Publication Number Publication Date
ZA200505214B true ZA200505214B (en) 2008-08-27

Family

ID=33131855

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200505214A ZA200505214B (en) 2003-03-31 2005-06-28 Preparation of quinapril hydrochloride

Country Status (22)

Country Link
US (1) US6858735B2 (xx)
EP (1) EP1611106B1 (xx)
JP (1) JP2006522092A (xx)
KR (1) KR20050115323A (xx)
CN (1) CN1747935A (xx)
AR (1) AR043949A1 (xx)
AT (1) ATE340161T1 (xx)
AU (1) AU2004226154B2 (xx)
BR (1) BRPI0408924A (xx)
CA (1) CA2517451C (xx)
CL (1) CL2004000541A1 (xx)
DE (1) DE602004002473T2 (xx)
DK (1) DK1611106T3 (xx)
ES (1) ES2271868T3 (xx)
MX (1) MXPA05010498A (xx)
PL (1) PL1611106T3 (xx)
PT (1) PT1611106E (xx)
RS (1) RS20050597A (xx)
RU (1) RU2298004C2 (xx)
TW (1) TWI284637B (xx)
WO (1) WO2004087671A1 (xx)
ZA (1) ZA200505214B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
US10278742B2 (en) 2012-11-12 2019-05-07 DePuy Synthes Products, Inc. Interbody interference implant and instrumentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
WO2002018321A2 (en) * 2000-08-29 2002-03-07 Abbott Laboratories Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor
US7482361B2 (en) * 2002-12-16 2009-01-27 Lupin Limited Crystalline form for quinapril hydrochloride and process for preparing the same

Also Published As

Publication number Publication date
US20040192613A1 (en) 2004-09-30
BRPI0408924A (pt) 2006-04-04
PT1611106E (pt) 2006-11-30
RU2005130402A (ru) 2006-02-10
CL2004000541A1 (es) 2005-02-04
RS20050597A (xx) 2007-09-21
TW200424177A (en) 2004-11-16
DE602004002473D1 (de) 2006-11-02
ES2271868T3 (es) 2007-04-16
US6858735B2 (en) 2005-02-22
AR043949A1 (es) 2005-08-17
JP2006522092A (ja) 2006-09-28
CN1747935A (zh) 2006-03-15
EP1611106B1 (en) 2006-09-20
WO2004087671A1 (en) 2004-10-14
DK1611106T3 (da) 2006-12-27
CA2517451C (en) 2009-04-21
KR20050115323A (ko) 2005-12-07
PL1611106T3 (pl) 2007-01-31
AU2004226154A1 (en) 2004-10-14
EP1611106A1 (en) 2006-01-04
TWI284637B (en) 2007-08-01
CA2517451A1 (en) 2004-10-14
MXPA05010498A (es) 2005-11-16
AU2004226154B2 (en) 2007-03-08
ATE340161T1 (de) 2006-10-15
DE602004002473T2 (de) 2007-06-14
RU2298004C2 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
PL378576A1 (pl) Wytwarzanie podstawionych chinazolin
EP1745573A4 (en) PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
EP1785131A4 (en) EXTERNAL PREPARATION OF TYPE S / O
IL172206A0 (en) Solid preparation
SI1802579T1 (sl) Derivati 3-arilaminopiridina
IL179558A0 (en) Irinotecan preparation
GB0421149D0 (en) Preparation of oxycodone
HK1116800A1 (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
PL1740204T3 (pl) Lecznicze zastosowanie alfa-mannozydazy
EP1712218A4 (en) HAARFÄRBEZUBEREITUNG
IL179331A0 (en) Preparation of levalbuterol hydrochloride
EP1595526A4 (en) PREPARATION OF CAPILLARY COLOR
ZA200505214B (en) Preparation of quinapril hydrochloride
AU2003298725A8 (en) Preparation of metallotexaphyrins
EP1725527A4 (en) IMPROVED MANUFACTURE OF ATORVASTATIN
SI1611106T1 (sl) Priprava kvinapril hidroklorida
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
GB0300455D0 (en) Meyhod of vaccine preparation
TW553243U (en) Structure of clotheshanger
GB0409250D0 (en) Preparation of cabergoline
TW582219U (en) Improved structure of flabellum
HUE037787T2 (hu) Alfa-mannozidáz gyógyászati alkalmazása
AU152460S (en) Set of components for construction games
GB0302713D0 (en) Trapping system of game